Suppr超能文献

基于超高效液相色谱-四极杆飞行时间质谱联用技术对独一味抗肝纤维化生物活性成分及分子机制的研究

UPLC-Q-TOF-MS based investigation into the bioactive compounds and molecular mechanisms of Lamiophlomis Herba against hepatic fibrosis.

作者信息

Chen Jingzi, Ge Jiaming, Chen Weisan, Zhao Ying, Song Tianbao, Fu Kun, Li Xiankuan, Zheng Yanchao

机构信息

Chinese Medicine Rehabilitation Department, Tianjin Nankai Hospital, Tianjin, 300100, China.

School of Chinese Materia Medical, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China; Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin 301617, China.

出版信息

Phytomedicine. 2023 Dec;121:155085. doi: 10.1016/j.phymed.2023.155085. Epub 2023 Sep 16.

Abstract

BACKGROUND

Lamiophlomis Herba (LH) is a valuable traditional medicinal plant found on the Qinghai-Tibetan Plateau that promotes blood circulation, removes blood stasis, and has antibacterial and anti-inflammatory properties. The main components of LH are iridoid glycosides, phenethyl alcohol glycosides, flavonoids, and polysaccharides.

PURPOSE

To investigate the mechanism of the anti-liver fibrosis effects of LH and screen for its bioactive compounds.

STUDY DESIGN

Screening LH marker components and validating the LH anti-liver fibrosis mechanism.

METHODS

The active ingredients of LH were identified using UPLC-Q-TOF-MS, and HotMap combined with principal components analysis (PCA) was used to screen for marker components. Network pharmacology and molecular docking techniques were used to predict the potential anti-fibrotic targets of LH. Immunofluorescence, enzyme-linked immunosorbent assay (ELISA), real-time PCR (RT-PCR), and western blotting were used for experimental validation and mechanistic studies.

RESULTS

Fifteen compounds that actively contributed to the cluster were identified as marker compounds. Acteoside, 8-O-acetyl shanzhiside methyl ester (8-O-ASME), Luteolin, Shanzhiside Methyl ester (SME), Loganin, Loganate were the main active components. Network pharmacology and molecular docking studies have shown that LH might improve liver fibrosis, inflammation, and oxidative stress, which might be related to key targets such as PTGS2, MAPK, EGFR, AKT1, SRC, Fn1, Col3a1, Col1a1, and PC-III. The results of ELISA, RT-PCR and western blot experiments showed that Acteoside, 8-O-ASME, Luteolin, SME, Loganin, Loganate, and the LH group could reduce the levels of fibronectin, Col1a1, Col3a1, α-SMA, Col-Ⅳ, LN, and PC-Ⅲ.

CONCLUSION

LH improves liver fibrosis induced by HSC-T6 cells and inhibits the deposition of extracellular matrix (ECM) in hepatocytes, resulting in a decrease in the degree of liver fibrosis and a good anti-liver fibrosis effect.

摘要

背景

独一味是青藏高原上一种珍贵的传统药用植物,具有促进血液循环、活血化瘀以及抗菌消炎的特性。独一味的主要成分有环烯醚萜苷、苯乙醇苷、黄酮类化合物和多糖。

目的

研究独一味抗肝纤维化作用的机制并筛选其生物活性化合物。

研究设计

筛选独一味标记成分并验证独一味抗肝纤维化机制。

方法

采用超高效液相色谱-四极杆飞行时间质谱(UPLC-Q-TOF-MS)鉴定独一味的活性成分,运用热图(HotMap)结合主成分分析(PCA)筛选标记成分。采用网络药理学和分子对接技术预测独一味潜在的抗纤维化靶点。通过免疫荧光、酶联免疫吸附测定(ELISA)、实时荧光定量聚合酶链反应(RT-PCR)和蛋白质印迹法进行实验验证和机制研究。

结果

确定了15种对聚类有积极贡献的化合物为标记化合物。毛蕊花糖苷、8-O-乙酰山栀苷甲酯(8-O-ASME)、木犀草素、山栀苷甲酯(SME)、马钱苷、马钱酸为主要活性成分。网络药理学和分子对接研究表明,独一味可能改善肝纤维化、炎症和氧化应激,这可能与环氧合酶-2(PTGS2)、丝裂原活化蛋白激酶(MAPK)、表皮生长因子受体(EGFR)、蛋白激酶B(AKT1)、原癌基因酪氨酸蛋白激酶(SRC)、纤连蛋白1(Fn1)、Ⅲ型胶原α1链(Col3a1)、Ⅰ型胶原α1链(Col1a1)和Ⅲ型前胶原(PC-III)等关键靶点有关。ELISA、RT-PCR和蛋白质印迹实验结果表明,毛蕊花糖苷、8-O-ASME、木犀草素、SME、马钱苷、马钱酸以及独一味组均可降低纤连蛋白、Col1a1、Col3a1、α-平滑肌肌动蛋白(α-SMA)、Ⅳ型胶原(Col-Ⅳ)、层粘连蛋白(LN)和PC-Ⅲ的水平。

结论

独一味可改善肝星状细胞-T6(HSC-T6)细胞诱导的肝纤维化,抑制肝细胞外基质(ECM)沉积,从而降低肝纤维化程度,具有良好的抗肝纤维化作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验